A randomised, placebo-controlled, incomplete block, three-way cross-over study to evaluate the effect of treatment with repeat inhaled doses of GW870086X on the allergen-induced early and late asthmatic response in subjects with mild asthma
- Registry ID
- EUCTR2007-005791-14
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- GlaxoSmithKline Research & Development Limited
- Start date
- 2009-02-05
- Completion date
- 2009-11-03
- Last update
- 2026-08-16
Conditions
Summary
To evaluate the effect of treatment with repeat inhaled doses of GW870086X once daily for 13 days on the late asthmatic response (LAR) to inhaled allergen in mild asthmatic subjects compared with placebo
Locations
View on source registry